BMC Geriatrics · Nov 17, 2026

Risk prediction models for progression from subjective cognitive decline to cognitive impairment: a systematic review and critical appraisal

By Zhao T, Wang Q, Liang S et al.

Background Subjective cognitive decline (SCD) refers to a self-perceived persistent decline in cognitive abilities despite normal performance on standard neuropsychological tests. Multivariable prediction models may estimate the individual risk of progression from SCD to cognitive impairment, but existing models have not been systematically evaluated. Objectives To systematically review and critically appraise prediction models for progression from SCD to cognitive impairment. Methods We systematically searched PubMed, Cochrane Library, Web of Science, Embase, China National Knowledge Infrastructure (CNKI), Wanfang Database and Chinese Biomedical Literature Service Database (SinoMed) for studies published between January 1, 2015 and January 19, 2026. Eligible studies included adults with SCD without cognitive impairment at baseline and developed and/or validated multivariable models predicting progression to mild cognitive impairment or dementia. Data were extracted using the CHARMS checklist, and risk of bias and applicability were assessed using PROBAST. Results Five studies reporting six prediction models were included. Development sample sizes ranged from 76 to 182 participants, with 2–51 predictors. Five models underwent internal validation only, one reported no validation, and none underwent independent external validation. Discrimination was commonly reported, whereas calibration and clinical utility were less consistently evaluated. Only two models reported calibration plots, with no quantitative calibration measures, and two assessed clinical utility using decision curve analysis. All six models were judged to be at high overall risk of bias, with concerns primarily arising from the Analysis domain. Considerable heterogeneity was observed in outcome definitions, follow-up duration, predictor composition, and modeling approaches. Conclusions The current evidence on prediction models for progression from SCD to cognitive impairment is limited and heterogeneous. Although some models demonstrated discriminative ability within their respective study populations, their performance and generalizability in independent SCD populations remain uncertain because of the lack of external validation and limited assessment of calibration and clinical utility. Future research should determine whether existing models require external validation, recalibration, updating, or redevelopment based on their methodological quality and performance. Rigorous evaluation in independent populations, transparent reporting, and assessment of calibration and clinical utility are needed before these models can be considered for clinical implementation.

doi.org/10.1186/s12877-026-08692-0Biomarkers

AgingResearch.News